TODD STRATEGY GROUP

Lobbying for VIAL HEALTH TECHNOLOGY, INC. · Vial is a clinical stage biopharmaceutical company.

Filing 4th Quarter - Termination

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $90,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Health Issues

New approach methods. FDA Roadmap.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem